http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2018006005-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cdb1ef9fe36ae01e3729156a7103103
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
filingDate 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4f4486727c5150134eb786c0a48d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57770bdf51c31ce1abbee22aaf5ca5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8bf38bacc35155fb8b8ee1441683ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91a073964469894cd406dd45020e7ab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd1b68bce7b37f8fdd983ea3be60d1b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2cd440902e08fc034aa7aa8d0e87de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d78ce4a07444fc6f1e5212d5d83341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63a7275ddbd2dae21803eb6bb5b8f3a2
publicationDate 2019-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2018006005-A
titleOfInvention FORMULATIONS THAT INCLUDE TENELIGLIPTIN OXALATE SALTS AND SOLVATOS OF THIS.
abstract The present invention relates to pharmaceutically acceptable formulations comprising salts of Teneligliptin oxalate and solvates thereof. Combinations with biguanides and the use of such pharmaceutically acceptable formulations for the treatment of glucose metabolism disorders are also provided.
priorityDate 2017-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11949652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592787

Total number of triples: 39.